An equine B cell surface antigen defined by a monoclonal antibody.

The research article describes the identification of a specific surface antigen found on B lymphocytes, a type of white blood cell in horses, using an antibody known as WS 65.

Identification of Equine B Cell Antigen

• The researchers identified a surface antigen (a protein that triggers an immune response) that is predominantly present on B lymphocytes in horses. This antigen was recognized by the Equine Leucocyte Antigen Workshop antibody WS 65.
• This identified antigen is not found on T cells, granulocytes, or thymocytes, suggesting that WS 65 specifically binds to B cells, making it a useful tool for studying these cells.

Immunohistochemistry

• Immunohistochemistry, a laboratory method that uses antibodies to identify specific proteins in tissue samples, was used to detect the presence of the antigen in the follicular areas of lymph nodes and in the splenic nodules. These results further confirmed the specificity of WS 65 for B cells.
• B cells from a horse with leukemia, even though they had surface immunoglobulins, did not express the antigen identified by WS 65.
• Moreover, equine leukemic T cells were also not labeled by WS 65, adding additional confirmation of its B cell specificity.

Immunoprecipitation and Molecular Characteristics

• The researchers used a technique called immunoprecipitation, which precipitates specific proteins from a solution by using antibodies, to identify the molecular size of the antigen recognized by WS 65.
• The identified antigen falls into the 85-90 kilodalton (kDa) range under reducing conditions, providing some initial information about its molecular characteristics.

Distinguishing Features of the B Cell Antigen

• The unique features of the identified B cell antigen differentiate it from surface immunoglobulin.
• It is not expressed on malignant B cells, which is an unusual trait, given surface immunoglobulins are usually present even on these diseased cells.

Significance

• The specific binding of WS 65 to B cells and the identification of this unique B cell antigen might lead to new insights into the functioning and pathology of equine B cells. It may also provide new therapeutic opportunities for equine B cell disorders.